CancerX Unveils Consortium Leadership Model to Better Harness Oncology Innovation
Moffitt Cancer Center
|
Contributed by: Kate Gamble
Summary
CancerX, a public-private partnership aimed at advancing cancer innovation, is transitioning to a consortium leadership model to better unite various stakeholders, including health systems, pharmaceutical companies, and startups. This shift, which will be led by five anchor organizations, including Advocate Health and Moffitt Cancer Center, seeks to enhance strategic programming in oncology care. Since its establishment, CancerX has cultivated a global network of over 150 organizations and initiated projects such as the CancerX Accelerator Program, focusing on using technology to improve cancer outcomes and equity. This development highlights a significant collaborative effort in healthcare technology, emphasizing the importance of public-private partnerships in addressing cancer treatment challenges.
